[Delimitation of the anthelmintic activity of albendazole. Study concerning human strongyloidiasis].
D000293:Adolescent; D000328:Adult; D000368:Aged; D015766:Albendazole; D000871:Anthelmintics / Q000008:administration & dosage / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013321:Strongyloides / Q000187:drug effects; D013322:Strongyloidiasis / Q000188:drug therapy*
D000871:Anthelmintics; D001562:Benzimidazoles; D015766:Albendazole
Demarcação da atividade anti-helmintica do albendazol. Estudo referente á estrongiloidíase humana.